Related Experiment Videos
[Highly differentiated primary liver cell carcinoma. 2 case reports]
1II. Medizinische Abteilung Allgemeines Krankenhaus Harburg.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|June 1, 1989
Summary
Hepatocellular carcinoma (HCC) diagnosis is challenging, especially for highly differentiated tumors. Regular sonography and alpha-fetoprotein (AFP) testing every six months are recommended for high-risk cirrhosis patients.
Area of Science:
- Hepatology and Oncology
- Diagnostic Imaging
Background:
- Hepatocellular carcinoma (HCC) is the most common primary liver tumor.
- Diagnosing highly differentiated HCC presents significant challenges.
- Various imaging modalities have differing diagnostic accuracies for HCC.
Observation:
- Sonography, CT, and scintigraphy can reliably detect focal liver lesions.
- Angiography offers limited value for diagnosing highly differentiated HCC due to non-specific malignancy criteria.
- Alpha-fetoprotein (AFP) is an unreliable biomarker for small, well-differentiated HCC.
Findings:
- Sonography and CT are the most effective imaging techniques for identifying liver focal findings.
- Angiography and AFP lack sufficient specificity for diagnosing early-stage, well-differentiated HCC.
- High-risk patients (e.g., HBV, hemochromatosis, alcohol-related cirrhosis) require vigilant monitoring.
Implications:
- Routine surveillance with sonography and AFP every six months is crucial for high-risk cirrhosis patients.
- This surveillance strategy aims for early detection of HCC, improving patient outcomes.
- Further research may refine imaging and biomarker utility in differentiating HCC subtypes.